Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Patupilone

Next Previous
Drug Profile

Patupilone

Alternative Names: EPO 906; Epothilone B

Latest Information Update: 24 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novartis
  • Class Antineoplastics; Epothilones
  • Mechanism of Action Mitosis inhibitors; Tubulin modulators; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Ovarian cancer
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Brain cancer; Breast cancer; Colorectal cancer; Liver cancer; Non-small cell lung cancer; Ovarian cancer; Prostate cancer

Most Recent Events

  • 30 Sep 2012 Novartis completes a phase II trial in Prostate cancer (Hormone-refractory, Metastatic disease) in Australia, Belgium, France, Germany, Italy, Singapore, Spain and USA (NCT00411528)
  • 13 Jun 2012 Novartis completes a phase I trial of patupilone in combination with everolimus in Solid tumours (refractory disease) in USA (NCT00496600)
  • 27 Aug 2011 Novartis completes a phase I trial in late-stage solid tumours in US (NCT00420524)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top